You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Descriptions of the variables used

From: Determinants of new drugs prescription in the Swiss healthcare market

Variables Share in % (if not specified differently)
Study Switzerland
Observed prescriptions (599,308 unique values)
 Generic drugs 19.30 n.a.a
 Rx 78.12 n.a.
 Age (mean) 14.59 n.a.
Markets (328 unique values)
 Number of treated patients (mean) 7054 n.a.
 Yearly treatment cost (mean) 469 n.a.
 HHI (mean) 0.56 n.a.
 Number of drugs in the market (mean) 18.5 n.a.
 Number of active substances (ATC 5th level) (mean) 2.97 n.a.
Patients (100,000 unique values)
 Age = 0-19 19.6 21.7
 Age = 20-39 21.6 27.0
 Age = 40-59 28.7 35.1
 Age = 60-79 23.5 11.6
 Age = 80+ 6.7 4.6
 Male 43.1 49.0
 Deductible >400 34.5 n.a.
 Co-morbidity index (ATC 3rd level) (mean) 4.8 n.a.
Physicians (9529 unique values)
 General practitioner (prescriptions’ share in %) 33.30 n.a.
 Independent specialist (prescriptions’ share in %) 57.63 n.a.
 Hospital (prescriptions’ share in %) 9.07 n.a.
Regions (9 unique values)
 Aarau (patients’ share in %) 9.79 19.33
 Basel-Stadt (patients’ share in %) 4.35 6.30
 Fribourg (patients’ share in %) 9.29 8.62
 Geneva (patients’ share in %) 24.60 14.62
 Jura (patients’ share in %) 0.81 2.35
 Neuchâtel (patients’ share in %) 6.86 5.72
 Ticino (patients’ share in %) 9.47 10.94
 Vaud (patients’ share in %) 25.88 22.21
 Valais (patients’ share in %) 8.94 9.90
  1. athese numbers were not available at the time of our study